Heartflow, Inc. Common Stock
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- John Farquhar
- Full Time Employees
- 843
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 135 Main Street San Francisco CA United States of America 94105
- IPO Date
- Aug 7, 2025
- CIK
- 0001464521
- Website
- heartflow.com
- Similar Companies
- Business
- HeartFlow, Inc. is a medical technology firm that delivers advanced non-invasive solutions globally for the assessment and management of coronary artery disease. Through its HeartFlow Platform, the company leverages artificial intelligence and computational fluid dynamics to construct a unique three-dimensional cardiac model from a routine coronary computed tomography angiography, a specialized imaging technique that yields detailed visuals of the heart's vessels. This advanced platform offers critical insights into coronary blood flow, the degree of arterial narrowing (stenosis), and the characteristics of plaque, thereby enhancing diagnostic capabilities beyond conventional non-invasive assessments. These capabilities help clinicians identify the significance of blockages and avoid unnecessary invasive procedures. Established in 2007, the company maintains its headquarters in Mountain View, California.
Company News
Bank of New York Mellon Corp Makes New $19.10 Million Investment in Heartflow, Inc. $HTFL
BlackRock Inc. Makes New $152.50 Million Investment in Heartflow, Inc. $HTFL
Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half
Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference
HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?
HeartFlow: An Impressive MedTech Growth Play
Why Heartflow Stock Soared Today
HeartFlow Shares Soar Following Strong Q2 Results and Upgraded Guidance
HeartFlow, Inc. (HTFL) Q2 2026 Earnings Call Transcript
Heartflow Q2 Earnings Call Highlights
HeartFlow (HTFL) Reports Q2 Loss, Beats Revenue Estimates
Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
Here Are Friday’s Top Wall Street Analyst Research Calls: Blackstone Mortgage, Boston Scientific, Edison International, Ford, GoDaddy, International Paper, Roblox, Saia, and More
What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors?
HeartFlow: A Premium AI Diagnostics Story
New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026?
Baron Discovery Fund Q1 2026: Who Moved The Needle